BNTX

#4574
BioNTech SE American Depositary Share
110.23
+2.01%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
110.23
110.48
Jahresspanne
81.20
123.98
Tagesänderung
+2.01%
Monatliche Änderung
-6.13%
6 month change
+7.02%
Jahresänderung
+2.54%
Vorheriger Schlusskurs
108.06
Open
110.48
Bid
Ask
Low
110.23
High
110.48
Volumen
78
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Nachrichten